Related Content
Gregg Stone, M.D., director of cardiovascular research and education at Columbia University Medical Center / New York ...
March 15, 2016 โ An independent panel of experts convened by the U.S. Food and Drug Administration (FDA) voted 9 to 0 ...
February 29, 2016 โ Abbott has initiated a voluntary safety notice regarding the MitraClip Delivery System to reinforce ...
February 2, 2016 โ Abbott announced that it has acquired private medical device company Kalila Medical Inc. Kalila ...
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel is set to review data and offer ...
Tom Watson, clinical analyst for MDBuyLine, and DAIC Editor Dave Fornell discuss some of the new cardiovascular and ...
October 30, 2015 โ Results from a clinical trial showed that that the Abbott Absorb everolimus-eluting bioresorbable ...
Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for ...
October 23, 2015 โ Results of the TUXEDO trial, designed to compare two types of stents in diabetic patients, found ...
October 16, 2015 โ Results from a clinical trial showed that Abbott's Absorb everolimus-eluting bioresorbable vascular ...